ZHE JIANG DAYANG BIOTECH GROUP CO., LTD.

Zhe Jiang Dayang Biotech Group Co., Ltd.

003017

CNE100004736

Commodity Chemicals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
17.91 ^CNY	-0.22%		-1.16%	-26.36%

May. 22	Zhe Jiang Dayang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023	CI
Apr. 28	Zhejiang Xinzhichun Semiconductor Materials Co., Ltd. announced that it has received CNY 14.7143 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd.	CI

Tranche Update on Zhejiang Dayang Biology Technology Co.,Ltd.'s Equity Buyback Plan announced on November 26, 2021.

June 15, 2022 at 11:40 pm EDT

From April 1, 2022 to June 14, 2022, the company has repurchased 2,212,100 shares, representing 3.72% for CNY 67.83 million. With this, the company has completed the repurchase of 2,800,000 shares, representing 4.7% for CNY 88.09 million under the buyback announced on November 26, 2021.

Latest news about Zhe Jiang Dayang Biotech Group Co., Ltd.

Zhe Jiang Dayang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023	May. 21	CI
Zhejiang Xinzhichun Semiconductor Materials Co., Ltd. announced that it has received CNY 14.7143 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd.	Apr. 27	CI
Zhe Jiang Dayang Biotech Group Co., Ltd. Proposes Final Cash Dividend for 2023	Apr. 26	CI
Tranche Update on Zhe Jiang Dayang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	Apr. 02	CI
Zhe Jiang Dayang Biotech Group Co., Ltd. announces an Equity Buyback for CNY 84 million worth of its shares.	Feb. 05	CI
Zhe Jiang Dayang Biotech Group Co., Ltd. authorizes a Buyback Plan.	Feb. 01	CI
Zhejiang Dayang Biotech Group Co., Ltd. Approves Interim Cash Dividend for the Year 2023, Payable on November 14, 2023	Nov. 08	CI
Certain A Shares of Zhejiang Dayang Biology Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 27-OCT-2023.	23-10-26	CI
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23	CI
Zhejiang Dayang Biotech Group Co., Ltd. Approves Interim Cash Dividend for the Year 2023	23-09-20	CI
Zhejiang Dayang Biotech Group Co., Ltd. Announces the Profit Distribution Proposal for the First Half of 2023	23-08-30	CI
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Fujian Shunyue Technology Co., Ltd. announced that it expects to receive CNY 96.672753 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd.	23-08-27	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 29 June 2023	23-06-20	CI
Dayang Biotech Vice Chairman Dies of Illness	23-05-22	MT
Zhejiang Dayang Biology Technology Co.,Ltd. Approves Cash Dividend for the Year 2022	23-05-16	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Proposes Cash Profit Distribution for 2022	23-04-25	CI
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-23	CI
Zhejiang Dayang Biotech Sells Idle Properties	22-12-27	MT
Zhejiang Dayang Biology Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-23	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-21	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 08, 2022	22-07-01	CI
Tranche Update on Zhejiang Dayang Biology Technology Co.,Ltd.'s Equity Buyback Plan announced on November 26, 2021.	22-06-15	CI
Zhejiang Dayang Biology Technology Co.,Ltd.'s Equity Buyback announced on November 26, 2021, has expired with 2,800,000 shares, representing 4.7% for CNY 88.09 million.	22-06-13	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Approves Final Cash Dividend for the Year 2021	22-05-12	CI

Chart Zhe Jiang Dayang Biotech Group Co., Ltd.

Duration

Period

Chart Zhe Jiang Dayang Biotech Group Co., Ltd.

More charts

Company Profile

Zhejiang Dayang Biotech Group Co Ltd is a China-based company mainly engaged in the production and sales of chemical raw materials such as inorganic salts and veterinary raw materials. The Company's main products include potassium carbonate, potassium bicarbonate, amproline hydrochloride, 2-chloro-6-fluorobenzaldehyde, etc. Its products are used in food, pesticide, fertilizer, medicine and glass fields. The Company conducts its businesses within the Chinese market and to overseas markets.

Sector

Commodity Chemicals

Calendar

2024-08-15 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Commodity Chemicals

	1st Jan change	Capi.
ZHE JIANG DAYANG BIOTECH GROUP CO., LTD.	-26.36%	198M
AIR LIQUIDE	+2.46%	102B
SABIC	-8.98%	60.79B
PT CHANDRA ASRI PACIFIC TBK	+74.76%	48.86B
WANHUA CHEMICAL GROUP CO., LTD.	+13.97%	37.96B
LYONDELLBASELL INDUSTRIES N.V.	+4.56%	32.37B
WESTLAKE CORPORATION	+14.72%	20.64B
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+11.17%	16.58B
HENGLI PETROCHEMICAL CO.,LTD.	+8.81%	13.93B
RONGSHENG PETROCHEMICAL CO., LTD.	-3.19%	13.25B